GCC Healthcare Concerns: Key Challenges and Solutions for Residents

By Melike Belenli Gümüş

November 19, 2024

The article from Middle East Health, titled “What are GCC residents’ healthcare concerns?” and authored by Dr. Basil Al Sharef and Dr. Mayada Elnegouly of CMC Hospital Dubai, highlights the pressing healthcare concerns faced by residents in the Gulf Cooperation Council (GCC) region. Notably, the survey conducted by CMC Hospital Dubai reveals significant insights into these healthcare concerns.

Healthcare Concerns

Lifestyle diseases are becoming a major concern in the GCC. A recent survey involving 1,680 residents from the United Arab Emirates (UAE), Kingdom of Saudi Arabia (KSA), Qatar, and Kuwait identified the top healthcare concerns. The primary concerns include:

Obesity, Diabetes, and Musculoskeletal Issues: 23% of respondents reported these as their top healthcare concerns. Obesity and diabetes are interlinked conditions that are approaching epidemic proportions in the region, largely due to lifestyle factors such as excessive fat leading to insulin resistance.

Surgically-Related Digestive Diseases: 26% of respondents identified digestive diseases, particularly those requiring surgical intervention like colorectal cancer and inflammatory bowel disease (IBD), as a significant concern.

These conditions are linked, as obesity often leads to insulin resistance, a precursor to type 2 diabetes. The International Diabetes Federation (IDF) reports that the GCC has some of the highest diabetes rates globally, driven by sedentary lifestyles and diets high in sugar and fat.

Furthermore, obesity contributes to liver diseases, such as metabolic-associated steatotic liver disease (MASLD) and non-alcoholic steatohepatitis (NASH). These conditions can lead to cirrhosis and liver cancer if not addressed early.

Causes and Implications

Lifestyle Factors: The rise in chronic diseases is attributed to changing lifestyle patterns. Sedentary lifestyles and poor physical activity contribute to musculoskeletal problems, such as back, neck, and spine issues.

Early Diagnosis and Treatment: The article emphasises the importance of early diagnosis to prevent irreversible damage from chronic musculoskeletal issues. Delays in seeking help often stem from fears related to surgical intervention or misdiagnosis.

Healthcare System and Infrastructure

Healthcare Expenditure: The GCC region has seen significant investment in healthcare, with expenditure growing from $86.8 billion in 2020 to $104.1 billion in 2022. This investment reflects the region’s commitment to improving healthcare services.

Quality of Care: Despite the investments, challenges persist regarding the quality and accessibility of care. The article highlights the need for a collaborative approach involving governments, healthcare providers, educators, and individuals to address these healthcare concerns.

Preventive Measures and Future Directions

Prevention Over Treatment: The authors advocate for focusing on prevention rather than solely treating illnesses. A culture of health, promoting preventive measures, and investing in advanced healthcare solutions are essential.
Population Engagement: Emphasising community involvement in healthcare reform efforts is crucial. Understanding people’s priorities helps integrate their voices into policy and reform initiatives.

Regional Variations

Country-Specific Concerns: The survey noted variations in healthcare concerns across different GCC countries. For example, digestive diseases were particularly concerning in Kuwait, while musculoskeletal issues were more prevalent there as well.

Conclusion

The article highlights the need for a multifaceted approach to address the growing healthcare concerns in the GCC region. Emphasising preventive care, enhancing early diagnosis and treatment, and ensuring equitable access to high-quality healthcare services are paramount. Involving various stakeholders and integrating population feedback will be crucial for aligning healthcare reforms with people’s needs.

Reference url

Recent Posts

Mavyret acute hepatitis C
         

Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implications

🌟 Did you know that the FDA has just approved the first-ever treatment specifically for acute Hepatitis C?

AbbVie’s Mavyret (glecaprevir/pibrentasvir) is now set to improve the way we think about HCV interventions, enabling earlier treatment to reduce long-term complications and improve patient outcomes. This approval not only addresses an urgent public health need but also aligns with evolving healthcare delivery models focused on cost-effective solutions.

Curious to learn more about the implications of this significant advancement in hepatitis care? Review the full article for insightful analysis on the future of HCV treatment!

#SyenzaNews #HealthcareInnovation #MarketAccess #HealthEconomics

HIV vaccine trials
    

Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies

🌍 Are we finally making strides in the fight against HIV?

Recent phase 1 vaccine trials using mRNA technology have shown promising results in activating immune responses that could lead to broadly neutralizing antibodies (bnAbs). This innovative approach not only addresses HIV’s rapid mutation but also offers critical insights for high-prevalence regions.

Dive into the full article to explore how these trials could shape the future of HIV prevention and what it means for global health!

#SyenzaNews #globalhealth #HIV #clinicaltrials

EHK clusters 2026 report
       

EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Cost Pharmaceuticals

🚀 Are you curious about how the Dutch healthcare system is adapting to high-cost pharmaceuticals?

The latest EHK clusters report for 2026 brings crucial updates to the risk-equalization model, enhancing equity among health insurers while closely managing skyrocketing costs. With innovative clustering techniques and revised reimbursement figures, these changes aim to improve access and accountability in an increasingly competitive healthcare landscape.

Dive into the full article to uncover the implications for health economics and policy!

#SyenzaNews #HealthEconomics #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.